Nanomedicine and Nanoscale Delivery (Focus Group - NND)

(226) System of fluorescent nanogels functionalized with glucosamine capable of crossing the BBB

(277) Astrocyte Membrane-Coated Nanoparticles: A Targeted Therapeutic Strategy for Glioblastoma Treatment

(278) Melting the Iceberg – Nanomedicines-driven Matrix Remodeling and Immune Recruitment in PDAC

(279) Creating a novel implant for controlled release to improve radiation sensitivity in prostate cancer

(280) Hyaluronic Acid-Functionalised pH-Responsive Nano-cocktails Targeting Breast Cancer Stem Cells

(281) Lyotropic liquid crystalline mesophases for restoring glutathione peroxidase after oxidative stress

(284) Evaluation of Vaccine Induced Antitumor Response of Cationic Nanoparticles in Colorectal Cancer

(285) Investigating the Cellular Internalization and Endosomal Escape of Polymeric Mesoscale Nanoparticles

(286) In vivo metabolism of cholesterol-containing nanoparticles generates immune modulatory oxysterols

(287) Inhalable TPGS/DPPC Micelles Co-Loaded with Curcumin and Icariin for Targeted Lung Cancer Therapy

(288) Investigating the potential of Dual-drug-loaded Electrospun Nanofibers for Breast Cancer Treatment

(289) Peptide-Guided Nanoparticles for Targeted Temozolomide Delivery in Glioblastoma

(290) Precision-Activated Masked Antibodies Reduce Immune Toxicities in Checkpoint blockade Cancer Therapy

(291) Biological evaluation of lycopene-loaded silica-based nanoparticle for vulvovaginal candidiasis

(292) The Development of Long-acting Teriparatide Formulations to Treat Osteoporosis

(293) Advancing Idiopathic Pulmonary Fibrosis treatment with PROTAC Nanomedicine

(294) A biomimetic redox-responsive hybrid lipid polymer antibiotic-nanocarrier against bacterial sepsis

(295) Inducing Mucosal Immunity in IPV Immunization Using Retinoid Derivative-Encapsulated Nanoparticles

(296) Enhancing mRNA-LNP Efficacy: Investigating the Role of Ionisable and Cationic Lipid Combinations

(297) Urease-powered nanomotors for enhancing bladder cancer chemotherapy

(298) Behavior of Lipid Nanoparticles in Aqueous Formulations

(299) The potential effect of L-carnosine loaded hyalurosomes as a novel anti-aging nano-cosmeceutical gel

(300) Optimization of amiloride-loaded nanoparticles for podocyte injury in glomerular disease.

(301) Drug-loaded cyclodextrin-based polymers to treat pulmonary infections

(302) PLGA Nanobots for therapeutic siRNA delivery: A novel strategy for bladder cancer therapy

(303) Optimizing LNP-RNA Formulations: Key Insights into Size, Zeta Potential, and Stability

(304) Targeted mRNA delivery to metastatic tumors using functionalized nanoparticles

(305) Ratiometric coloaded human serum albumin nanoparticles for effective breast cancer treatment

(306) Polyelectrolyte Complexes as Versatile Vehicles for the Controlled Release of Cefazolin.

(307) API stability improvement using Cyclodextrins: a comparative study of SBEbCD vs HPbCD

(308) Machine Learning-derived Insights in Design of Small Polymeric Nanoparticles for Gene Delivery

(309) A Two-component Two-step Transformable Nanoplatform against Cancers Based on Bioorthogonal Chemistry

(310) Conventional vs PEG-modified PLGA nanoparticles for sodium channel blockade in neuropathic pain

(311) LinTT1 peptide-functionalized Camptothesome enhances tumor delivery, boosting anti-cancer efficacy.

(312) Biodistribution, Pharmacokinetics and Acute Toxicity of Disulfide Crosslinked P(AAm-co-MAA) Nanogels

(313) Tiny Particles, Big Plans: Nanoparticles for Controlling Drug Transfer through the Placental Barrier

(314) Enhanced anti-sarcopenic activity of perindopril erbumine using ultradeformable liposomes

(315) Self-Immolative Polymeric Prodrug for Targeted Cancer Therapy through Disturbing the Redox Balance

(316) Lipidic Nanoparticle for Brain-targeted Treatment in Bacterial Meningitis

(317) Novel Non-Aqueous Emulsification-based Microsphere Platform for Sustained Delivery of Proteins

(318) Phenylboronic acid functionalized poly (lactic-co-glycolic acid) nanoparticles towards lung cancer

(319) Multifunctional nanoparticles to fight hormone-resistant prostate cancer

(320) Engineered Nanobubbles for Inducing Unprogrammed Necrosis in Cancer Immunortherapy

(321) Biodynamers, dynamic protein nanorods, potentiate antibiotics via membrane interactions

(322) pH-dependent Zinc Ion and Photosensitizer Release Nanoparticles for Cancer Targeting Treatment

(323) Electrospinning of nanofibers and the perspectives for dermatological application

(324) pH-sensitive Ionizable Lipid-based Nanoparticles for siRNA delivery to Liver

(325) Enhanced Solubility & Anti-Dilution Properties of Lipophilic Drugs with Solid Micellar Nanoparticles

(326) Nanoparticles-mediated codelivery of cell cycle blockers for the treatment of prostate cancer

(327) Sphingomyelin-derived nanovesicles for the delivery epacadostat enhance melanoma immunotherapy

(328) Engineering Extended-Release Profiles for Biologics via Crosslinking of Poloxamer 407 Hydrogels

(329) Mannosylated Lipid Nanoparticles for Targeted in Vivo mRNA Delivery

(330) Immunoliposomes as a targeted delivery system for enzyme replacement therapy in Fabry disease

(331) 1-Min Nanocrystals: A Fast, Cost-Effective and Efficient Technique to Mill Drugs Using Speed Mixer

(332) Controlled Release of Fluticasone Propionate after Intra-Articular Injection of EP-104IAR in Sheep

(333) Targeted IL-10 mRNA Lipid Nanoparticles Improve Outcomes in Experimental Intracerebral Hemorrhage

(334) Immunomodulatory effects of cholesterol oxidation and their implications in liposomal drug delivery

(335) Endoscopic Delivery of Regorafenib-Curcumin Microparticles to Locally Treat Colorectal Cancer

(336) Targeting Serpinb9 via Gemcitabine-based SiRNA/Drug Nanocarrier to Improve Pancreatic Cancer Therapy

(337) Use of gamma-alumina for acyclovir release

(338) Inhaled lipid nanocarriers for the eradication of pseudomonal biofilms in cystic fibrotic lungs

(339) Lipophilization as a design strategy to tune the release of Tofacitinib from lipid nanoparticles

(340) Thermoresponsive GPNMB-Hydrogels as an Innovative Therapeutic Strategy for Bone Regeneration

(341) Liposome-Encapsulated Bacteriophage Therapy for Drug-Resistant Mycobacterium abscessus

(342) Development of PLGA-Based Nanoparticles for a novel therapeutic peptide in Cardiovascular Diseases

(343) In vitro release testing system development for buprenorphine in situ forming implant

(344) Local Extended-Release Colchicine for Intra-Articular Treatment of Gout Flares

(345) Optimized HPLC Method for TX & FV Estimation in Plasma & Brain: Pharmacokinetics & Biodistribution

(346) Nano-in-micro particles for the pulmonary delivery of remdesivir

(347) An Ultra-long-acting Atovaquone Prodrug Formulation for Malaria Chemoprophylaxis

(348) Effective screening of LNP formulations with centrifugal microfluidics devices

(349) Ginsenoside-Gemcitabine Nanocomplex-based Delivery System for Enhanced Cancer Therapy

(350) Targeting alveolar macrophages with sialic acid-decorated liposomes

(351) An ultra-long-acting prodrug of buprenorphine for opioid dependence

(352) Ionic liquid-based nanoemulsion to improve sorafenib oral absorption & repurposing it in AML therapy

(353) Controlled Release of Gemcitabine with Partially Molecular Imprinted Microspheres for Cancer Therapy

(354) Microneedle enabled dual drug delivery system for vaginal infections using magnetic hyperthermia

(355) Evaluation of Apisolex™ for Parenteral Use: Solubilizing Poorly Soluble Small Molecules and PROTACs

(356) Rational development of donepezil-curcumin intranasal nanotherapies for Alzheimer’s disease

(357) Microfluidics Manufacturing of Liposomal Adjuvants

(358) Marginated Neutrophils Compete for Pulmonary Endothelial-targeted Nanoparticles, part of the RES

(359) Exosome-Liposome Fusion System for Targeted Treatment of MCAO-Induced Brain Injury

(360) Hybrid nanoparticles with TGFβ1 EVs and cartilage-targeting liposomes for osteoarthritis treatment

(361) INFECTION-RESPONSIVE THERANOSTIC SYSTEM FOR PREVENTING & MONITORING SURGICAL & WOUND SITE INFECTIONS

(362) Bioinspired Polymer-Membrane Insulin Crystal Enables Long-Term, Self-Regulated Release

(363) The Extended Potentiated Anticoagulant Effect of Novel Warfarin-α-Tocopherol–Chitosan Nanoparticles

(364) Evaluation of triazine-based lipid nanoparticle (LNP) formulation for mRNA delivery in a mouse model

(365) Hybrid nanoparticles leveraging cell-cell interactions for immunotherapy & metabolic Modulation

(366) Effect of Pegylayion on liposomal adhesion on breast cancer tumor

(367) Insulin-Gold Nanoplatform: Boosting Antibody-Drug Conjugate Efficacy

(368) Refining peptide-functionalized LNPs for enhanced tumor-targeted mRNA delivery

(369) Nanoparticles enhance gemcitabine efficacy by overcoming fibroblast barriers in pancreatic cancer

(370) Lyophilization approach to improve long-term stability of LGA-PEI nanoparticles for drug delivery

(371) Development of a High-Concentration Fulvestrant Depot Formulation with Sustained Release Properties

(372) Surface modification of sustainably-formulated bacterial cellulose nanoparticles for drug delivery

(373) Biodegradable silica-based ultra long-acting tirzepatide formulations for the treatment of obesity

(374) Advancements in Lyophilized Exosomes for Enhanced Stability and Therapeutic Applications

(375) Exploring the Impact of Iron Availability on Antibiotic Resistance in Mycobacterium Species

(376) Design and Screening of Ionizable Lipids for Precision mRNA Delivery to Extrahepatic Organs

(377) Highly Porous Microparticles with TLR7 Agonist-3 Liposomes and siTGF-β LNPs for Pulmonary Fibrosis

(378) Dextran-based T-cell expansion nanoparticles for ex vivo generation of efficacious CAR T cells

(379) Actively targeting colorectal cancer using nanoparticles co-loaded with small molecule inhibitors

(380) Synthesis and non-covalent interaction investigation of metformin-conjugated poly(methyl acrylate)

(381) Towards Understanding LAI Suspensions: Impact of Size Reduction Techniques and Aggregation State

(382) Development of EGFR-Targeted Dual-Loaded Polymeric Nanoparticles for Triple Negative Breast Cancer

(383) Physically Crosslinked Nanocomposite Hydrogels for Sustained Subcutaneous Delivery of Peptides

(384) Development of a solid lipid nanoparticle platform for the delivery of vancomycin

(385) Impact of nanomaterials on the anti-Candida activity of cysteine-modified amidated decoralin

(386) Evaluation of the biocidal activity of Origanum vulgare L. essential oil in nanoemulsion

(387) Polymer-lipid hybrid nanoparticles for sonographic monitoring of subcutaneous fat reduction

(388) Multi-Functional Polymer Nanoparticles for Localized Fat Reduction

(389) Week-long normoglycaemia in diabetic mice and pigs via a dose of glucose-responsive insulin complex

(390) Gas-Driven Fat Reduction with PEG-Based Nanocarriers

(391) Engineered Nanovaccines for STING-Activated Antigen Cross-Presentation in Cancer Immunotherapy

(392) In Vitro Evaluation of Ionizable Lipids in Lipid Nanoparticle (LNP) Formulations.

(393) Budesonide- nanoparticles based inhaled therapy for potential treatment of COPD

(394) Optimizing supramolecular and chemical stability to enhance the design of self-assembling prodrugs

(395) Quantification of Payloads in Lipid Nanoparticles by Scatter-Free UV/Visible Absorption Spectroscopy

(396) Development an injectable in situ formulation of targeted liposomal cisplatin for chemoradiotherapy

(397) Polymeric nanoparticles delivering bevacizumab and avoiding hyperglycolysis in glioblastoma therapy

(399) Paclitaxel-Based Prodrug Hydrogelators

(400) Plasmonic enhanced femtosecond laser anticancer drug delivery using gold-lipid nanoparticles

(401) Design of Supramolecular Hydrogelators for Enhanced Drug Loading and Sustained Therapeutic Release

(402) CD44-Targeted Antibody-Drug Conjugates with Cathepsin B-Cleavable Linker for Ovarian Cancer Therapy

(403) Nicotinamide-loaded Peptoid Nanotubes for Energy Regeneration in Brain Injury

(404) Design, Optimization and Evaluation of Tazarotene Loaded Emulgel Formulation for Treatment of Acne

(405) Antiretroviral Supramolecular Prodrug Hydrogelators as Long-Acting Injectables

(406) Co-delivery of TLR7/8 agonist and Dox using targeted liposome nanocarrier for bladder cancer therapy

(407) AI and Human Based Design of High-Complexity Nano-Therapies for KRAS-Driven Cancer

(408) Development and assessment of a BCS class II drug in the form of solid lipid nanoparticle

(409) Directed discovery of high-loading nanoaggregates enabled by drug-matched oligo-peptide excipients

(410) Investigation of nifedipine and piperine loaded Bio-SNEDDS for the treatment of hypertension

(411) Disruption of the airway mucus barrier enhances nebulized RNA delivery to reverse pulmonary fibrosis

(412) Preparation and characterization of Eudragit S 100 nanoparticles

(413) Antioxidative HABN Targeting Activated Hepatic Stellate Cells for Anti-Hepatic-Fibrosis Therapy

(414) pH-Responsive Doxorubicin Dimeric Nanoassemblies with High Loading, Stability, and Tumor Selectivity

(415) Development of an EZH2 PROTAC-Nanoparticle targeting Breast Cancer Brain Metastases

(416) VCAM-Targeted Delivery of MFSD2A mRNA Mitigates Blood-Brain Barrier Dysfunction in Ischemic Stroke

(417) Developing LNPs for Pediatric Acute Myeloid Leukemia through Two Biological Mechanisms

(418) A 3D Co-Culture Model of Lipid Nanoparticle Uptake in Senescent Pancreatic Cancer

(419) Immuno-Nanoparticles Co-Delivering Rifampicin and Vit D3 for Macrophage-Targeted TB Treatment

(420) Towards Clinical Translation of Autophagy Inhibitor BAQ13 LNP (TR002) for Cancer Therapy

(421) A Novel Long-acting Injectable Formulation Enabling Sustained Release of Dutasteride over 3 months

(423) A novel one month long acting injection (LAI) technology for prolonged release of leuprorelin

(446) Targeted LNPs for Improved In Vivo mRNA Delivery and Immune Responses

(473) Enhancing Therapeutic Efficacy and Immune Response with Bispecific Gold Nanoparticles in Cancer

(510) Comparative ex vivo permeability through healthy and inflamed skin hydrophilic and hydrophobic >500 Da drugs using lipid-based nanovesicles